Eye Health 115 27
Total Page：16
File Type：pdf, Size：1020Kb
Load more
Recommended publications
-
Management of Microtropia
Br J Ophthalmol: first published as 10.1136/bjo.58.3.281 on 1 March 1974. Downloaded from Brit. J. Ophthal. (I974) 58, 28 I Management of microtropia J. LANG Zirich, Switzerland Microtropia or microstrabismus may be briefly described as a manifest strabismus of less than 50 with harmonious anomalous correspondence. Three forms can be distinguished: primary constant, primary decompensating, and secondary. There are three situations in which the ophthalmologist may be confronted with micro- tropia: (i) Amblyopia without strabismus; (2) Hereditary and familial strabismus; (3) Residual strabismus after surgery. This may be called secondary microtropia, for everyone will admit that in most cases of convergent strabismus perfect parallelism and bifoveal fixation are not achieved even after expert treatment. Microtropia and similar conditions were not mentioned by such well-known early copyright. practitioners as Javal, Worth, Duane, and Bielschowsky. The views of Maddox (i898), that very small angles were extremely rare, and that the natural tendency to fusion was much too strong to allow small angles to exist, appear to be typical. The first to mention small residual angles was Pugh (I936), who wrote: "A patient with monocular squint who has been trained to have equal vision in each eye and full stereoscopic vision with good amplitude of fusion may in 3 months relapse into a slight deviation http://bjo.bmj.com/ in the weaker eye and the vision retrogresses". Similar observations of small residual angles have been made by Swan, Kirschberg, Jampolsky, Gittoes-Davis, Cashell, Lyle, Broadman, and Gortz. There has been much discussion in both the British Orthoptic Journal and the American Orthoptic journal on the cause of this condition and ways of avoiding it. -
Pupillary Disorders LAURA J
13 Pupillary Disorders LAURA J. BALCER Pupillary disorders usually fall into one of three major cat- cortex generally do not affect pupillary size or reactivity. egories: (1) abnormally shaped pupils, (2) abnormal pupillary Efferent parasympathetic fibers, arising from the Edinger– reaction to light, or (3) unequally sized pupils (anisocoria). Westphal nucleus, exit the midbrain within the third nerve Occasionally pupillary abnormalities are isolated findings, (efferent arc). Within the subarachnoid portion of the third but in many cases they are manifestations of more serious nerve, pupillary fibers tend to run on the external surface, intracranial pathology. making them more vulnerable to compression or infiltration The pupillary examination is discussed in detail in and less susceptible to vascular insult. Within the anterior Chapter 2. Pupillary neuroanatomy and physiology are cavernous sinus, the third nerve divides into two portions. reviewed here, and then the various pupillary disorders, The pupillary fibers follow the inferior division into the orbit, grouped roughly into one of the three listed categories, are where they then synapse at the ciliary ganglion, which lies discussed. in the posterior part of the orbit between the optic nerve and lateral rectus muscle (Fig. 13.3). The ciliary ganglion issues postganglionic cholinergic short ciliary nerves, which Neuroanatomy and Physiology initially travel to the globe with the nerve to the inferior oblique muscle, then between the sclera and choroid, to The major functions of the pupil are to vary the quantity of innervate the ciliary body and iris sphincter muscle. Fibers light reaching the retina, to minimize the spherical aberra- to the ciliary body outnumber those to the iris sphincter tions of the peripheral cornea and lens, and to increase the muscle by 30 : 1. -
Taking the Mystery out of Abnormal Pupils
Taking the mystery out of abnormal pupils No financial disclosures Course Title: Taking the mystery out [email protected] of abnormal pupils Lecturer: Brad Sutton, OD, FAAO Clinical Professor IU School of Optometry . •Review of Anatomy Iris anatomy Iris sphincter Iris dilator Parasympathetic pathway Sympathetic pathway Parasympathetic Pathway Parasympathetic Pathway Light stimulates the retina then impulse Four neuron arc travels with the ganglion cells through the Retina to the pretectal nucleus in the chiasm into the optic tracts. 80% go to the midbrain (1) LGN , 20% to the pretectal nuclei.They Pretectal nucleus to the EW nucleus (2) then hemidecussate and terminate at the EW nucleus EW nucleus to the ciliary ganglion (3) Ciliary ganglion to the iris sphincter with short ciliary nerves (4) 1 Points of Interest Sympathetic Pathway Within the second order neuron there are Three neuron arc 30 near response fibers for every light Posterior hypothalamus to ciliospinal response fiber. This allows for light - near center of Budge ( C8 - T2 ). (1) dissociation. Center of Budge to the superior cervical The third order neuron runs with cranial ganglion in the neck (2) nerve III from the brain stem to the ciliary Superior cervical ganglion to the dilator ganglion. Superficially located prior to the muscle (3) cavernous sinus. Points of Interest Second order neuron runs along the surface of the lung, can be affected by a Pancoast tumor Third order neuron runs with the carotid artery then with the ophthalmic division of cranial nerve V 2 APD Testing testing……………….AKA……… … APD / reverse APD Direct and consensual response Which is the abnormal pupil ? Very simple rule. -
Pediatric Ophthalmology/Strabismus 2017-2019
Academy MOC Essentials® Practicing Ophthalmologists Curriculum 2017–2019 Pediatric Ophthalmology/Strabismus *** Pediatric Ophthalmology/Strabismus 2 © AAO 2017-2019 Practicing Ophthalmologists Curriculum Disclaimer and Limitation of Liability As a service to its members and American Board of Ophthalmology (ABO) diplomates, the American Academy of Ophthalmology has developed the Practicing Ophthalmologists Curriculum (POC) as a tool for members to prepare for the Maintenance of Certification (MOC) -related examinations. The Academy provides this material for educational purposes only. The POC should not be deemed inclusive of all proper methods of care or exclusive of other methods of care reasonably directed at obtaining the best results. The physician must make the ultimate judgment about the propriety of the care of a particular patient in light of all the circumstances presented by that patient. The Academy specifically disclaims any and all liability for injury or other damages of any kind, from negligence or otherwise, for any and all claims that may arise out of the use of any information contained herein. References to certain drugs, instruments, and other products in the POC are made for illustrative purposes only and are not intended to constitute an endorsement of such. Such material may include information on applications that are not considered community standard, that reflect indications not included in approved FDA labeling, or that are approved for use only in restricted research settings. The FDA has stated that it is the responsibility of the physician to determine the FDA status of each drug or device he or she wishes to use, and to use them with appropriate patient consent in compliance with applicable law. -
Complete and Incomplete Forms of the Benign Disorder Characterised By
Br J Ophthalmol: first published as 10.1136/bjo.16.8.449 on 1 August 1932. Downloaded from THE BRITISH JOURNAL OF OPHTHALMOLOGY AUGUST, 1932 COMMUNICATIONS COMPLETE AND INCOMPLETE FORMS OF THE BENIGN DISORDER CHARACTERISED BY TONIC PUPILS AND ABSENT copyright. TENDON REFLEXES BY W. J. ADIE, M.D., F.R.C.P. PHYSICIAN, CHARING CROSS HOSPITAL AND ROYAL LONDON OPHTHALMIC HOSPITAL. OUT-PATIENT PHYSICIAN, THE NATIONAL HOSPITAL FOR NERVOUS DISEASES, QUEEN SQUARE http://bjo.bmj.com/ IN earlier papers on this subject it has been suggested that certain apparently dissimilar abnormal pupillary reactions formerly described as occurring in unrelated conditions are manifestations of the same disorder. The abnormal reactions are, on the one hand, the tonic pupillary reaction (syn. pupillotonia, myotonic reaction, tonic convergence reaction of pupils apparently inactive to light, on September 30, 2021 by guest. Protected Marcus's peculiar pupil phenomenon, non-luetic Argyll Robertson pupil, pseudo-Argyll Robertson pupil) and, on the other hand what may be called atypical phases of the tonic pupil. In the atypical phases tonic reactions are absent or difficult to detect and the state of the pupil in cases that present them is usually desig- nated by the term fixed pupil, ophthalmoplegia interna, iridoplegia or partial iridoplegia, of unknown origin. The disorder referred to, if the views expressed here are correct, may manifest itself in the following clinical forms: A. The complete form characterized by the presence in one or both eyes of the tonic convergence reaction in a pupil apparently Br J Ophthalmol: first published as 10.1136/bjo.16.8.449 on 1 August 1932. -
Approved and Unapproved Abbreviations and Symbols For
Facility: Illinois College of Optometry and Illinois Eye Institute Policy: Approved And Unapproved Abbreviations and Symbols for Medical Records Manual: Information Management Effective: January 1999 Revised: March 2009 (M.Butz) Review Dates: March 2003 (V.Conrad) March 2008 (M.Butz) APPROVED AND UNAPPROVED ABBREVIATIONS AND SYMBOLS FOR MEDICAL RECORDS PURPOSE: To establish a database of acceptable ocular and medical abbreviations for patient medical records. To list the abbreviations that are NOT approved for use in patient medical records. POLICY: Following is the list of abbreviations that are NOT approved – never to be used – for use in patient medical records, all orders, and all medication-related documentation that is either hand-written (including free-text computer entry) or pre-printed: DO NOT USE POTENTIAL PROBLEM USE INSTEAD U (unit) Mistaken for “0” (zero), the Write “unit” number “4”, or “cc” IU (international unit) Mistaken for “IV” (intravenous) Write “international unit” or the number 10 (ten). Q.D., QD, q.d., qd (daily) Mistaken for each other Write “daily” Q.O.D., QOD, q.o.d., qod Period after the Q mistaken for Write (“every other day”) (every other day) “I” and the “O” mistaken for “I” Trailing zero (X.0 mg) ** Decimal point is missed. Write X mg Lack of leading zero (.X mg) Decimal point is missed. Write 0.X mg MS Can mean morphine sulfate or Write “morphine sulfate” or magnesium sulfate “magnesium sulfate” MSO4 and MgSO4 Confused for one another Write “morphine sulfate” or “magnesium sulfate” ** Exception: A trailing zero may be used only where required to demonstrate the level of precision of the value being reported, such as for laboratory results, imaging studies that report size of lesions, or catheter/tube sizes. -
Injections, Vaccines, and Other Physician-Administered Drugs Codes
INDIANA HEALTH COVERAGE PROGRAMS PROVIDER CODE TABLES Injections, Vaccines, and Other Physician-Administered Drugs Codes Note: Due to possible changes in Indiana Health Coverage Programs (IHCP) policy or national coding updates, inclusion of a code on the code tables does not necessarily indicate current coverage. See IHCP Banner Pages and Bulletins and the IHCP Fee Schedules for updates to coding, coverage, and benefit information. For information about using these code tables, see the Injections, Vaccines, and Other Physician-Administered Drugs provider reference module. Table 1 – Procedure Codes for Botulinum Toxin Injections Table 2 – Procedure Codes for Chemodenervation for Use with Botulinum Toxin Injections Table 3 – ICD-10 Diagnosis Codes for Medical Necessity of Botulinum Toxin Injections Table 1 – Procedure Codes for Botulinum Toxin Injections Reviewed/Updated: July 1, 2020 Procedure Code Code Description J0585 Injection, onabotulinumtoxin A, 1 unit J0586 Injection, abobotulinumtoxin A, 5 units J0587 Injection, rimabotulinumtoxin B, 100 units J0588 Injection, incobotulinumtoxin A, 1 unit Published: September 17, 2020 1 Indiana Health Coverage Programs Injections, Vaccines, and Other Physician-Administered Drugs Codes Table 2 – Procedure Codes for Chemodenervation for Use with Botulinum Toxin Injections Reviewed/Updated: July 1, 2020 Procedure Code Definition 42699 Unlisted procedure, salivary glands or ducts Esophagoscopy, flexible, transoral; with directed submucosal injection(s), 43201 any substance Esophagogastroduodenoscopy, -
GAZE and AUTONOMIC INNERVATION DISORDERS Eye64 (1)
GAZE AND AUTONOMIC INNERVATION DISORDERS Eye64 (1) Gaze and Autonomic Innervation Disorders Last updated: May 9, 2019 PUPILLARY SYNDROMES ......................................................................................................................... 1 ANISOCORIA .......................................................................................................................................... 1 Benign / Non-neurologic Anisocoria ............................................................................................... 1 Ocular Parasympathetic Syndrome, Preganglionic .......................................................................... 1 Ocular Parasympathetic Syndrome, Postganglionic ........................................................................ 2 Horner Syndrome ............................................................................................................................. 2 Etiology of Horner syndrome ................................................................................................ 2 Localizing Tests .................................................................................................................... 2 Diagnosis ............................................................................................................................... 3 Flow diagram for workup of anisocoria ........................................................................................... 3 LIGHT-NEAR DISSOCIATION ................................................................................................................. -
Classification of Strabismus
Classification of strabismus Pr Dr Monique Cordonnier Université Libre de Bruxelles Most prominent feature to have in mind = BINOCULAR VISION potential ? Yes or No If the strabismus was present during the first 6- 8 months of life, there is no This potential means that potential for treatment (……) may restore normal binocular binocularity, warranting vision stability and avoiding recurrences Binocular vision = eyes are like wheels on the rails of a railtrack 1 What is BINOCULAR VISION ? 1. Normal - Bifoveolar fixation with normal visual acuity in each eye, no strabismus, no diplopia, normal retinal correspondence, normal fusional vergence amplitudes, normal stereopsis. 2. Subnormal (abnormal) – 1 or more of the following; anomalous retinal correspondence, suppression, deficient to no stereopsis, amblyopia, decreased fusional vergence amplitudes. 3. Absence of Binocular Vision - no simultaneous perception, no fusion, no stereopsis Besides, the classification of strabismus is based on a number of features including : . The relative position of the eyes . The time of onset (=clue for binocular vision potential), . Whether the deviation is intermittent (=clue for binocular vision potential) or constant . Whether the deviation is comitant (supranuclear cause) or incomitant (nuclear or infranuclear cause, clue for binocular vision potential if the eyes are straight in one position) . According to the associated refractive error (accommodative strabismus) 2 Most common types of strabismus in children Supranuclear causes Paralytic, muscular or -
9781441967237.Pdf
The Neurologic Diagnosis wwwwwwwwww Jack N. Alpert The Neurologic Diagnosis A Practical Bedside Approach Jack N. Alpert, MD St. Luke’s Episcopal Hospital Department of Neurology University of Texas Medical School at Houston Houston, TX, USA [email protected] ISBN 978-1-4419-6723-7 e-ISBN 978-1-4419-6724-4 DOI 10.1007/978-1-4419-6724-4 Springer New York Dordrecht Heidelberg London Library of Congress Control Number: 2011941214 © Springer Science+Business Media, LLC 2012 All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher (Springer Science+Business Media, LLC, 233 Spring Street, New York, NY 10013, USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed is forbidden. The use in this publication of trade names, trademarks, service marks, and similar terms, even if they are not identifi ed as such, is not to be taken as an expression of opinion as to whether or not they are subject to proprietary rights. While the advice and information in this book are believed to be true and accurate at the date of going to press, neither the authors nor the editors nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein. Printed on acid-free paper Springer is part of Springer Science+Business Media (www.springer.com) In Memory of Morris B. -
International Council of Ophthalmology Residency Curriculum
International Council of Ophthalmology Residency Curriculum International Council of Ophthalmology 945 Green Street San Francisco, CA 94133 United States of America www.icoph.org © 2006, 2012 by The International Council of Ophthalmology All rights reserved. First edition 2006 Second edition 2012. International Council of Ophthalmology Residency Curriculum Introduction “Teaching the Teachers” The International Council of Ophthalmology (ICO) is committed to leading efforts to improve ophthalmic education to meet the growing need for eye care worldwide. To enhance educational programs and ensure best practices are available, the ICO focuses on "Teaching the Teachers," and offers curricula, conferences, courses, and resources to those involved in ophthalmic education. By providing ophthalmic educators with the tools to become better teachers, we will have better-trained ophthalmologists and professionals throughout the world, with the ultimate result being better patient care. Launched in 2012, the ICO’s Center for Ophthalmic Educators, educators.icoph.org, offers a broad array of educational tools, resources, and guidelines for teachers of residents, medical students, subspecialty fellows, practicing ophthalmologists, and allied eye care personnel. The Center enables resources to be sorted by intended audience and guides ophthalmology teachers in the construction of web-based courses, development and use of assessment tools, and applying evidence-based strategies for enhancing adult learning. The interactive feature, “Connections,” is the Center’s dynamic focal point, where ophthalmic educators can share ideas and collaborate with peers. The Center builds on the ICO’s original interactive online educational presence: World Ophthalmology Residency Development (WORD), which was developed in 2008 by Eduardo Mayorga, MD, ICO Director for E-Learning, and Gabriela Palis, MD, Editor-in-Chief, Center for Ophthalmic Educators. -
Z-Rpt Procedure Code Published Table
ForwardHealth Diagnosis Code-Restricted Physician-Administered Drug The following table contains information on diagnosis-restricted physician administered drugs. For each drug, the corresponding HCPCS procedure code and ICD-10 diagnosis code(s) and disease description(s) are listed. When one of the drugs is billed for a disease state listed for the drug, the drug does not require prior authorization (PA). When billing one of these drugs for a disease that is not listed below, PA is required. Peer-reviewed medical literature supporting the efficacy of the drug for the disease state must be submitted with the PA request. The information above only applies to billing of these services on a professional claim. Note: This table includes Wisconsin Medicaid’s most current information and may be updated periodically. HCPCS* Description Effective: 10/1/2017 J0205 INJECTION, ALGLUCERASE, PER 10 UNITS (CEREDASE) ICD-10 Description E7522 GAUCHER DISEASE J0585 INJECTION, ONABOTULINUMTOXINA, 1 UNIT (BOTOX)** Allowable diagnosis codes for members of any age. See next section for members 18 years and older with migraines. ICD-10 Description G114 HEREDITARY SPASTIC PARAPLEGIA G2402 DRUG INDUCED ACUTE DYSTONIA G2409 OTHER DRUG INDUCED DYSTONIA G241 GENETIC TORSION DYSTONIA G242 IDIOPATHIC NONFAMILIAL DYSTONIA G243 SPASMODIC TORTICOLLIS G245 BLEPHAROSPASM G248 OTHER DYSTONIA G2589 OTHER SPECIFIED EXTRAPYRAMIDAL AND MOVEMENT DISORDERS G35 MULTIPLE SCLEROSIS G512 MELKERSSON'S SYNDROME G513 CLONIC HEMIFACIAL SPASM G514 FACIAL MYOKYMIA G518 OTHER DISORDERS